Periodic Reporting for period 1 - MIRAGE (MicroRNAs as therapeutic targets for ARVC.)

Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a genetic cardiac disease mainly characterised by the progressive substitution of the myocardium with fatty or fibro-fatty tissue. Although initially thought to be rare, ARVC is the second most common cause of...